印度糖尿病缓解 (DiRemI) 研究:一个潜在的匹配对照试验的协议
Pramod Tripathi1,2, Nidhi Kadam1, Diptika Tiwari1
1Department of Research, Freedom From Diabetes Research Foundation, Pune, Maharashtra, India.
PloS one
|June 28, 2024
概括
这项研究表明,综合的生活方式干预可以帮助管理印度的2型糖尿病 (T2D). 该计划结合了饮食,运动和支持减肥和糖尿病缓解.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 生活方式 医学 医疗
背景情况:
- 2型糖尿病 (T2D) 是一个日益严重的全球健康问题,特别是在印度.
- 有效的T2D管理受到有限的认识,财务障碍和文化因素的阻碍.
- 现有的研究往往忽略了除了饮食之外的全面的生活方式干预措施.
研究的目的:
- 评估印度T2D患者的一年整合生活方式干预.
- 评估干预措施在减肥和糖尿病缓解方面的有效性.
- 在T2D管理中解决印度人口在T2D管理中的独特需求.
主要方法:
- 潜在的,开放的标签,匹配组试验.
- 一年的在线强化生活方式干预 (ILI) 与常规医疗护理 (RMC).
- ILI包括饮食,运动,心理支持和T2D患者的医疗管理 (30-70岁,BMI 25-35,<15年的疾病持续时间).
主要成果:
- 共同主要结局:体重减轻和糖尿病缓解在12个月.
- 在18个月后进行后续检查.
- 样本规模:360名参与者 (每组180人).
结论:
- 该DiRemI研究是印度第一个针对T2D的大规模缓解研究.
- 证明了T2D缓解和并发症管理的综合方法的有效性.
- 在全球范围内提供基于证据的T2D管理策略的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165
Pathophysiology of Diabetes
918
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
918


